nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—migraine—Prednisone—atopic dermatitis	0.646	1	CpDpCtD
Ergotamine—CYP3A4—Pimecrolimus—atopic dermatitis	0.0282	0.111	CbGbCtD
Ergotamine—ABCB1—Tacrolimus—atopic dermatitis	0.028	0.11	CbGbCtD
Ergotamine—CYP1A2—Diphenhydramine—atopic dermatitis	0.0235	0.0922	CbGbCtD
Ergotamine—ABCB1—Loratadine—atopic dermatitis	0.0205	0.0806	CbGbCtD
Ergotamine—ABCB1—Methylprednisolone—atopic dermatitis	0.0188	0.0738	CbGbCtD
Ergotamine—CYP3A4—Tacrolimus—atopic dermatitis	0.0168	0.066	CbGbCtD
Ergotamine—CYP3A4—Loratadine—atopic dermatitis	0.0123	0.0483	CbGbCtD
Ergotamine—ABCB1—Betamethasone—atopic dermatitis	0.0122	0.048	CbGbCtD
Ergotamine—ABCB1—Prednisolone—atopic dermatitis	0.012	0.0473	CbGbCtD
Ergotamine—ABCB1—Hydrocortisone—atopic dermatitis	0.0114	0.0449	CbGbCtD
Ergotamine—ABCB1—Prednisone—atopic dermatitis	0.0114	0.0447	CbGbCtD
Ergotamine—CYP3A4—Methylprednisolone—atopic dermatitis	0.0112	0.0442	CbGbCtD
Ergotamine—CYP3A4—Triamcinolone—atopic dermatitis	0.00852	0.0335	CbGbCtD
Ergotamine—CYP3A4—Betamethasone—atopic dermatitis	0.00731	0.0287	CbGbCtD
Ergotamine—CYP3A4—Prednisolone—atopic dermatitis	0.00721	0.0284	CbGbCtD
Ergotamine—ABCB1—Dexamethasone—atopic dermatitis	0.0071	0.0279	CbGbCtD
Ergotamine—CYP3A4—Hydrocortisone—atopic dermatitis	0.00684	0.0269	CbGbCtD
Ergotamine—CYP3A4—Prednisone—atopic dermatitis	0.00681	0.0268	CbGbCtD
Ergotamine—CYP3A4—Dexamethasone—atopic dermatitis	0.00425	0.0167	CbGbCtD
Ergotamine—Pain—Desonide—atopic dermatitis	0.000679	0.0198	CcSEcCtD
Ergotamine—Vertigo—Dimenhydrinate—atopic dermatitis	0.000639	0.0186	CcSEcCtD
Ergotamine—Vertigo—Diphenhydramine—atopic dermatitis	0.000639	0.0186	CcSEcCtD
Ergotamine—Tachycardia—Dimenhydrinate—atopic dermatitis	0.000566	0.0165	CcSEcCtD
Ergotamine—Tachycardia—Diphenhydramine—atopic dermatitis	0.000566	0.0165	CcSEcCtD
Ergotamine—Pruritus—Desonide—atopic dermatitis	0.000562	0.0164	CcSEcCtD
Ergotamine—Pain—Fluocinonide—atopic dermatitis	0.00055	0.0161	CcSEcCtD
Ergotamine—Paraesthesia—Dimenhydrinate—atopic dermatitis	0.000521	0.0152	CcSEcCtD
Ergotamine—Paraesthesia—Diphenhydramine—atopic dermatitis	0.000521	0.0152	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Pimecrolimus—atopic dermatitis	0.000511	0.0149	CcSEcCtD
Ergotamine—Paraesthesia—Pimecrolimus—atopic dermatitis	0.000504	0.0147	CcSEcCtD
Ergotamine—Pain—Pimecrolimus—atopic dermatitis	0.00048	0.014	CcSEcCtD
Ergotamine—Hypertension—Loratadine—atopic dermatitis	0.000473	0.0138	CcSEcCtD
Ergotamine—Myalgia—Loratadine—atopic dermatitis	0.000466	0.0136	CcSEcCtD
Ergotamine—Pruritus—Fluocinonide—atopic dermatitis	0.000455	0.0133	CcSEcCtD
Ergotamine—Vertigo—Fluocinolone Acetonide—atopic dermatitis	0.000442	0.0129	CcSEcCtD
Ergotamine—Bradycardia—Tacrolimus—atopic dermatitis	0.000437	0.0128	CcSEcCtD
Ergotamine—Tachycardia—Loratadine—atopic dermatitis	0.000436	0.0127	CcSEcCtD
Ergotamine—Hypoaesthesia—Tacrolimus—atopic dermatitis	0.000427	0.0125	CcSEcCtD
Ergotamine—Asthenia—Dimenhydrinate—atopic dermatitis	0.000416	0.0121	CcSEcCtD
Ergotamine—Asthenia—Diphenhydramine—atopic dermatitis	0.000416	0.0121	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Loratadine—atopic dermatitis	0.000407	0.0119	CcSEcCtD
Ergotamine—Paraesthesia—Loratadine—atopic dermatitis	0.000401	0.0117	CcSEcCtD
Ergotamine—Myalgia—Mometasone—atopic dermatitis	0.0004	0.0117	CcSEcCtD
Ergotamine—Pruritus—Pimecrolimus—atopic dermatitis	0.000397	0.0116	CcSEcCtD
Ergotamine—Pain—Loratadine—atopic dermatitis	0.000382	0.0111	CcSEcCtD
Ergotamine—Vomiting—Dimenhydrinate—atopic dermatitis	0.000369	0.0108	CcSEcCtD
Ergotamine—Vomiting—Diphenhydramine—atopic dermatitis	0.000369	0.0108	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Fluocinolone Acetonide—atopic dermatitis	0.000366	0.0107	CcSEcCtD
Ergotamine—Vomiting—Pimecrolimus—atopic dermatitis	0.000357	0.0104	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Mometasone—atopic dermatitis	0.000349	0.0102	CcSEcCtD
Ergotamine—Nausea—Dimenhydrinate—atopic dermatitis	0.000345	0.0101	CcSEcCtD
Ergotamine—Nausea—Diphenhydramine—atopic dermatitis	0.000345	0.0101	CcSEcCtD
Ergotamine—Paraesthesia—Mometasone—atopic dermatitis	0.000344	0.01	CcSEcCtD
Ergotamine—Pain—Fluocinolone Acetonide—atopic dermatitis	0.000343	0.01	CcSEcCtD
Ergotamine—Vertigo—Tacrolimus—atopic dermatitis	0.000336	0.0098	CcSEcCtD
Ergotamine—Nausea—Pimecrolimus—atopic dermatitis	0.000333	0.00972	CcSEcCtD
Ergotamine—Pain—Mometasone—atopic dermatitis	0.000328	0.00957	CcSEcCtD
Ergotamine—Hypertension—Tacrolimus—atopic dermatitis	0.000323	0.00942	CcSEcCtD
Ergotamine—Asthenia—Loratadine—atopic dermatitis	0.000321	0.00935	CcSEcCtD
Ergotamine—Myalgia—Tacrolimus—atopic dermatitis	0.000318	0.00929	CcSEcCtD
Ergotamine—Tachycardia—Tacrolimus—atopic dermatitis	0.000298	0.00869	CcSEcCtD
Ergotamine—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000284	0.00829	CcSEcCtD
Ergotamine—Vomiting—Loratadine—atopic dermatitis	0.000284	0.00829	CcSEcCtD
Ergotamine—Bradycardia—Prednisolone—atopic dermatitis	0.000279	0.00815	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	0.000278	0.00811	CcSEcCtD
Ergotamine—Asthenia—Mometasone—atopic dermatitis	0.000275	0.00803	CcSEcCtD
Ergotamine—Paraesthesia—Tacrolimus—atopic dermatitis	0.000274	0.00799	CcSEcCtD
Ergotamine—Bradycardia—Hydrocortisone—atopic dermatitis	0.000273	0.00796	CcSEcCtD
Ergotamine—Pruritus—Mometasone—atopic dermatitis	0.000271	0.00791	CcSEcCtD
Ergotamine—Nausea—Loratadine—atopic dermatitis	0.000265	0.00774	CcSEcCtD
Ergotamine—Pain—Tacrolimus—atopic dermatitis	0.000261	0.00761	CcSEcCtD
Ergotamine—Bradycardia—Triamcinolone—atopic dermatitis	0.000257	0.00749	CcSEcCtD
Ergotamine—Bradycardia—Methylprednisolone—atopic dermatitis	0.000256	0.00748	CcSEcCtD
Ergotamine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000255	0.00745	CcSEcCtD
Ergotamine—Vomiting—Mometasone—atopic dermatitis	0.000244	0.00711	CcSEcCtD
Ergotamine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000239	0.00696	CcSEcCtD
Ergotamine—Bradycardia—Betamethasone—atopic dermatitis	0.000233	0.0068	CcSEcCtD
Ergotamine—Bradycardia—Dexamethasone—atopic dermatitis	0.000233	0.0068	CcSEcCtD
Ergotamine—Nausea—Mometasone—atopic dermatitis	0.000228	0.00664	CcSEcCtD
Ergotamine—Asthenia—Tacrolimus—atopic dermatitis	0.000219	0.00639	CcSEcCtD
Ergotamine—Pruritus—Tacrolimus—atopic dermatitis	0.000216	0.0063	CcSEcCtD
Ergotamine—Vertigo—Prednisolone—atopic dermatitis	0.000215	0.00626	CcSEcCtD
Ergotamine—Vertigo—Hydrocortisone—atopic dermatitis	0.00021	0.00611	CcSEcCtD
Ergotamine—Hypertension—Prednisolone—atopic dermatitis	0.000206	0.00602	CcSEcCtD
Ergotamine—Bradycardia—Prednisone—atopic dermatitis	0.000203	0.00592	CcSEcCtD
Ergotamine—Hypertension—Hydrocortisone—atopic dermatitis	0.000201	0.00588	CcSEcCtD
Ergotamine—Myalgia—Hydrocortisone—atopic dermatitis	0.000199	0.00579	CcSEcCtD
Ergotamine—Vertigo—Triamcinolone—atopic dermatitis	0.000197	0.00576	CcSEcCtD
Ergotamine—Vertigo—Methylprednisolone—atopic dermatitis	0.000197	0.00574	CcSEcCtD
Ergotamine—Vomiting—Tacrolimus—atopic dermatitis	0.000194	0.00566	CcSEcCtD
Ergotamine—Tachycardia—Prednisolone—atopic dermatitis	0.00019	0.00555	CcSEcCtD
Ergotamine—Hypertension—Triamcinolone—atopic dermatitis	0.00019	0.00553	CcSEcCtD
Ergotamine—Hypertension—Methylprednisolone—atopic dermatitis	0.000189	0.00552	CcSEcCtD
Ergotamine—Myalgia—Triamcinolone—atopic dermatitis	0.000187	0.00546	CcSEcCtD
Ergotamine—Myalgia—Methylprednisolone—atopic dermatitis	0.000187	0.00544	CcSEcCtD
Ergotamine—Tachycardia—Hydrocortisone—atopic dermatitis	0.000186	0.00542	CcSEcCtD
Ergotamine—Nausea—Tacrolimus—atopic dermatitis	0.000181	0.00529	CcSEcCtD
Ergotamine—Vertigo—Betamethasone—atopic dermatitis	0.000179	0.00522	CcSEcCtD
Ergotamine—Vertigo—Dexamethasone—atopic dermatitis	0.000179	0.00522	CcSEcCtD
Ergotamine—Paraesthesia—Prednisolone—atopic dermatitis	0.000175	0.00511	CcSEcCtD
Ergotamine—Tachycardia—Triamcinolone—atopic dermatitis	0.000175	0.0051	CcSEcCtD
Ergotamine—Tachycardia—Methylprednisolone—atopic dermatitis	0.000175	0.00509	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000173	0.00506	CcSEcCtD
Ergotamine—Hypertension—Dexamethasone—atopic dermatitis	0.000172	0.00502	CcSEcCtD
Ergotamine—Hypertension—Betamethasone—atopic dermatitis	0.000172	0.00502	CcSEcCtD
Ergotamine—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000171	0.00499	CcSEcCtD
Ergotamine—Myalgia—Dexamethasone—atopic dermatitis	0.00017	0.00495	CcSEcCtD
Ergotamine—Myalgia—Betamethasone—atopic dermatitis	0.00017	0.00495	CcSEcCtD
Ergotamine—Pain—Prednisolone—atopic dermatitis	0.000167	0.00486	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000163	0.00476	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000163	0.00475	CcSEcCtD
Ergotamine—Pain—Hydrocortisone—atopic dermatitis	0.000163	0.00475	CcSEcCtD
Ergotamine—Paraesthesia—Triamcinolone—atopic dermatitis	0.000161	0.0047	CcSEcCtD
Ergotamine—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000161	0.00469	CcSEcCtD
Ergotamine—Tachycardia—Dexamethasone—atopic dermatitis	0.000159	0.00463	CcSEcCtD
Ergotamine—Tachycardia—Betamethasone—atopic dermatitis	0.000159	0.00463	CcSEcCtD
Ergotamine—Vertigo—Prednisone—atopic dermatitis	0.000156	0.00455	CcSEcCtD
Ergotamine—Pain—Triamcinolone—atopic dermatitis	0.000153	0.00447	CcSEcCtD
Ergotamine—Hypertension—Prednisone—atopic dermatitis	0.00015	0.00437	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000148	0.00432	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000148	0.00432	CcSEcCtD
Ergotamine—Myalgia—Prednisone—atopic dermatitis	0.000148	0.00431	CcSEcCtD
Ergotamine—Paraesthesia—Dexamethasone—atopic dermatitis	0.000146	0.00426	CcSEcCtD
Ergotamine—Paraesthesia—Betamethasone—atopic dermatitis	0.000146	0.00426	CcSEcCtD
Ergotamine—Pain—Betamethasone—atopic dermatitis	0.000139	0.00406	CcSEcCtD
Ergotamine—Pain—Dexamethasone—atopic dermatitis	0.000139	0.00406	CcSEcCtD
Ergotamine—Tachycardia—Prednisone—atopic dermatitis	0.000138	0.00403	CcSEcCtD
Ergotamine—Asthenia—Hydrocortisone—atopic dermatitis	0.000137	0.00398	CcSEcCtD
Ergotamine—Pruritus—Hydrocortisone—atopic dermatitis	0.000135	0.00393	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000129	0.00376	CcSEcCtD
Ergotamine—Asthenia—Triamcinolone—atopic dermatitis	0.000129	0.00375	CcSEcCtD
Ergotamine—Asthenia—Methylprednisolone—atopic dermatitis	0.000128	0.00374	CcSEcCtD
Ergotamine—Paraesthesia—Prednisone—atopic dermatitis	0.000127	0.00371	CcSEcCtD
Ergotamine—Pruritus—Triamcinolone—atopic dermatitis	0.000127	0.0037	CcSEcCtD
Ergotamine—Pruritus—Methylprednisolone—atopic dermatitis	0.000127	0.00369	CcSEcCtD
Ergotamine—Vomiting—Hydrocortisone—atopic dermatitis	0.000121	0.00353	CcSEcCtD
Ergotamine—Asthenia—Betamethasone—atopic dermatitis	0.000117	0.0034	CcSEcCtD
Ergotamine—Asthenia—Dexamethasone—atopic dermatitis	0.000117	0.0034	CcSEcCtD
Ergotamine—Nausea—Prednisolone—atopic dermatitis	0.000116	0.00338	CcSEcCtD
Ergotamine—Pruritus—Betamethasone—atopic dermatitis	0.000115	0.00336	CcSEcCtD
Ergotamine—Pruritus—Dexamethasone—atopic dermatitis	0.000115	0.00336	CcSEcCtD
Ergotamine—Vomiting—Triamcinolone—atopic dermatitis	0.000114	0.00333	CcSEcCtD
Ergotamine—Vomiting—Methylprednisolone—atopic dermatitis	0.000114	0.00332	CcSEcCtD
Ergotamine—Nausea—Hydrocortisone—atopic dermatitis	0.000113	0.0033	CcSEcCtD
Ergotamine—Nausea—Triamcinolone—atopic dermatitis	0.000106	0.00311	CcSEcCtD
Ergotamine—Nausea—Methylprednisolone—atopic dermatitis	0.000106	0.0031	CcSEcCtD
Ergotamine—Vomiting—Betamethasone—atopic dermatitis	0.000103	0.00302	CcSEcCtD
Ergotamine—Vomiting—Dexamethasone—atopic dermatitis	0.000103	0.00302	CcSEcCtD
Ergotamine—Asthenia—Prednisone—atopic dermatitis	0.000102	0.00296	CcSEcCtD
Ergotamine—Pruritus—Prednisone—atopic dermatitis	0.0001	0.00292	CcSEcCtD
Ergotamine—Nausea—Betamethasone—atopic dermatitis	9.66e-05	0.00282	CcSEcCtD
Ergotamine—Nausea—Dexamethasone—atopic dermatitis	9.66e-05	0.00282	CcSEcCtD
Ergotamine—Vomiting—Prednisone—atopic dermatitis	9.01e-05	0.00263	CcSEcCtD
Ergotamine—Nausea—Prednisone—atopic dermatitis	8.42e-05	0.00245	CcSEcCtD
Ergotamine—HTR1D—Signaling Pathways—CXCL10—atopic dermatitis	1.73e-05	0.000266	CbGpPWpGaD
Ergotamine—HTR2A—GPCR ligand binding—CXCL8—atopic dermatitis	1.73e-05	0.000265	CbGpPWpGaD
Ergotamine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	1.72e-05	0.000264	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—CXCL10—atopic dermatitis	1.72e-05	0.000264	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—CCR5—atopic dermatitis	1.7e-05	0.000261	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—CXCL10—atopic dermatitis	1.7e-05	0.000261	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR ligand binding—CXCL8—atopic dermatitis	1.69e-05	0.00026	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TAC1—atopic dermatitis	1.69e-05	0.000259	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—NPS—atopic dermatitis	1.69e-05	0.000259	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—CCR5—atopic dermatitis	1.69e-05	0.000259	CbGpPWpGaD
Ergotamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	1.68e-05	0.000259	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—NFKBIA—atopic dermatitis	1.68e-05	0.000258	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—STAT6—atopic dermatitis	1.66e-05	0.000255	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CXCR3—atopic dermatitis	1.66e-05	0.000254	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—CCL5—atopic dermatitis	1.65e-05	0.000254	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—CCR5—atopic dermatitis	1.64e-05	0.000252	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—NPS—atopic dermatitis	1.63e-05	0.00025	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TAC1—atopic dermatitis	1.63e-05	0.00025	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—CCL5—atopic dermatitis	1.63e-05	0.00025	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—CCL5—atopic dermatitis	1.63e-05	0.00025	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TAC1—atopic dermatitis	1.62e-05	0.000249	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—NPS—atopic dermatitis	1.62e-05	0.000249	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—CCR5—atopic dermatitis	1.61e-05	0.000248	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—CCR5—atopic dermatitis	1.61e-05	0.000248	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CCR3—atopic dermatitis	1.61e-05	0.000247	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CXCR3—atopic dermatitis	1.6e-05	0.000246	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CXCL10—atopic dermatitis	1.59e-05	0.000245	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—CCL5—atopic dermatitis	1.59e-05	0.000245	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CXCR3—atopic dermatitis	1.59e-05	0.000244	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—CCR5—atopic dermatitis	1.58e-05	0.000243	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CCR3—atopic dermatitis	1.58e-05	0.000243	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR ligand binding—CXCL8—atopic dermatitis	1.57e-05	0.000241	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL5—atopic dermatitis	1.57e-05	0.000241	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—NPS—atopic dermatitis	1.55e-05	0.000239	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TAC1—atopic dermatitis	1.55e-05	0.000239	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CCR3—atopic dermatitis	1.55e-05	0.000238	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GLB1—atopic dermatitis	1.54e-05	0.000236	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CXCR3—atopic dermatitis	1.52e-05	0.000234	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL5—atopic dermatitis	1.51e-05	0.000233	CbGpPWpGaD
Ergotamine—HTR1D—GPCR downstream signaling—CXCL8—atopic dermatitis	1.51e-05	0.000233	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL5—atopic dermatitis	1.51e-05	0.000232	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—CCL5—atopic dermatitis	1.49e-05	0.000229	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—CCR5—atopic dermatitis	1.49e-05	0.000229	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CXCL10—atopic dermatitis	1.48e-05	0.000228	CbGpPWpGaD
Ergotamine—HTR1B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.48e-05	0.000228	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—CCL5—atopic dermatitis	1.48e-05	0.000227	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.47e-05	0.000226	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ADSL—atopic dermatitis	1.47e-05	0.000226	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—CCR5—atopic dermatitis	1.47e-05	0.000226	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—CCR5—atopic dermatitis	1.46e-05	0.000225	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—CCL5—atopic dermatitis	1.46e-05	0.000224	CbGpPWpGaD
Ergotamine—HTR1D—GPCR downstream signaling—IL2—atopic dermatitis	1.45e-05	0.000222	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL5—atopic dermatitis	1.44e-05	0.000222	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CCR3—atopic dermatitis	1.44e-05	0.000221	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—CCR5—atopic dermatitis	1.43e-05	0.00022	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TAC1—atopic dermatitis	1.43e-05	0.00022	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—NPS—atopic dermatitis	1.43e-05	0.00022	CbGpPWpGaD
Ergotamine—HTR1B—GPCR downstream signaling—IL2—atopic dermatitis	1.42e-05	0.000218	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—NPS—atopic dermatitis	1.41e-05	0.000216	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TAC1—atopic dermatitis	1.41e-05	0.000216	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CXCR3—atopic dermatitis	1.4e-05	0.000216	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.39e-05	0.000214	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CXCR3—atopic dermatitis	1.38e-05	0.000212	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—NGF—atopic dermatitis	1.38e-05	0.000212	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TAC1—atopic dermatitis	1.38e-05	0.000212	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NPS—atopic dermatitis	1.38e-05	0.000212	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—CXCL8—atopic dermatitis	1.37e-05	0.000211	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CCL5—atopic dermatitis	1.37e-05	0.000211	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—NGF—atopic dermatitis	1.35e-05	0.000208	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CXCR3—atopic dermatitis	1.35e-05	0.000208	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—CXCL8—atopic dermatitis	1.35e-05	0.000207	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—CCR5—atopic dermatitis	1.34e-05	0.000206	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—IL2—atopic dermatitis	1.34e-05	0.000206	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CXCL10—atopic dermatitis	1.34e-05	0.000206	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—CCR5—atopic dermatitis	1.33e-05	0.000205	CbGpPWpGaD
Ergotamine—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.33e-05	0.000205	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—IL2—atopic dermatitis	1.33e-05	0.000205	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL5—atopic dermatitis	1.33e-05	0.000204	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—CCR5—atopic dermatitis	1.31e-05	0.000202	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—IL2—atopic dermatitis	1.31e-05	0.000202	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL5—atopic dermatitis	1.31e-05	0.000201	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—CXCL8—atopic dermatitis	1.3e-05	0.000199	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	1.29e-05	0.000199	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—IL2—atopic dermatitis	1.29e-05	0.000198	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CXCL10—atopic dermatitis	1.28e-05	0.000198	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL5—atopic dermatitis	1.28e-05	0.000197	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	1.28e-05	0.000197	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	1.28e-05	0.000197	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CCL5—atopic dermatitis	1.28e-05	0.000196	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—NGF—atopic dermatitis	1.27e-05	0.000195	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—CXCL8—atopic dermatitis	1.27e-05	0.000195	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—CXCL8—atopic dermatitis	1.26e-05	0.000194	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	1.26e-05	0.000193	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—IL2—atopic dermatitis	1.24e-05	0.00019	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CCR5—atopic dermatitis	1.24e-05	0.00019	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CXCL10—atopic dermatitis	1.23e-05	0.000189	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—IL2—atopic dermatitis	1.21e-05	0.000187	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—IL2—atopic dermatitis	1.21e-05	0.000186	CbGpPWpGaD
Ergotamine—HTR1F—Signaling by GPCR—IL6—atopic dermatitis	1.21e-05	0.000186	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—CXCL8—atopic dermatitis	1.2e-05	0.000184	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	1.19e-05	0.000183	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.18e-05	0.000182	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—NGF—atopic dermatitis	1.18e-05	0.000182	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—CXCL8—atopic dermatitis	1.18e-05	0.000181	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.17e-05	0.00018	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CCL5—atopic dermatitis	1.15e-05	0.000177	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CCR5—atopic dermatitis	1.15e-05	0.000177	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—IL2—atopic dermatitis	1.14e-05	0.000176	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—IL6—atopic dermatitis	1.14e-05	0.000175	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—NFKBIA—atopic dermatitis	1.14e-05	0.000175	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.14e-05	0.000175	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	1.13e-05	0.000174	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.13e-05	0.000174	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—IL2—atopic dermatitis	1.12e-05	0.000173	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	1.12e-05	0.000173	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.12e-05	0.000172	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—IL2—atopic dermatitis	1.12e-05	0.000172	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—MAPK8—atopic dermatitis	1.12e-05	0.000172	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	1.12e-05	0.000172	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—NFKBIA—atopic dermatitis	1.11e-05	0.000171	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	1.11e-05	0.000171	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	1.11e-05	0.00017	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	1.09e-05	0.000168	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	1.08e-05	0.000166	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.08e-05	0.000165	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	1.07e-05	0.000165	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—NGF—atopic dermatitis	1.07e-05	0.000164	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—CXCL8—atopic dermatitis	1.06e-05	0.000163	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CCL5—atopic dermatitis	1.06e-05	0.000163	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—MAPK8—atopic dermatitis	1.05e-05	0.000162	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—NFKBIA—atopic dermatitis	1.05e-05	0.000161	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CCR5—atopic dermatitis	1.04e-05	0.00016	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—NGF—atopic dermatitis	1.03e-05	0.000158	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—IL2—atopic dermatitis	1.03e-05	0.000158	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	1.03e-05	0.000158	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—NGF—atopic dermatitis	1.02e-05	0.000157	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	1.02e-05	0.000157	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	1.02e-05	0.000156	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—IL2—atopic dermatitis	1.01e-05	0.000156	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	1e-05	0.000154	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	9.96e-06	0.000153	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	9.91e-06	0.000152	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—NGF—atopic dermatitis	9.81e-06	0.000151	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	9.8e-06	0.000151	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—CXCL8—atopic dermatitis	9.76e-06	0.00015	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CCL5—atopic dermatitis	9.76e-06	0.00015	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	9.75e-06	0.00015	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	9.75e-06	0.00015	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—NFKBIA—atopic dermatitis	9.74e-06	0.00015	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	9.61e-06	0.000148	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	9.55e-06	0.000147	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CCR5—atopic dermatitis	9.54e-06	0.000147	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	9.47e-06	0.000146	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	9.4e-06	0.000145	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—IL2—atopic dermatitis	9.33e-06	0.000143	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	9.32e-06	0.000143	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	9.13e-06	0.00014	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—NGF—atopic dermatitis	9.04e-06	0.000139	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PPARA—atopic dermatitis	9.03e-06	0.000139	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	9e-06	0.000138	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—NGF—atopic dermatitis	8.9e-06	0.000137	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	8.87e-06	0.000136	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	8.86e-06	0.000136	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—NFKBIA—atopic dermatitis	8.8e-06	0.000135	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CCR5—atopic dermatitis	8.79e-06	0.000135	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	8.74e-06	0.000134	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	8.71e-06	0.000134	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	8.67e-06	0.000133	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	8.65e-06	0.000133	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—IL2—atopic dermatitis	8.6e-06	0.000132	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	8.49e-06	0.000131	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	8.48e-06	0.00013	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	8.47e-06	0.00013	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	8.46e-06	0.00013	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	8.45e-06	0.00013	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	8.29e-06	0.000127	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—CXCL8—atopic dermatitis	8.12e-06	0.000125	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	8.09e-06	0.000124	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—NFKBIA—atopic dermatitis	8.09e-06	0.000124	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	8.06e-06	0.000124	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—CXCL8—atopic dermatitis	7.95e-06	0.000122	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	7.87e-06	0.000121	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IL2—atopic dermatitis	7.76e-06	0.000119	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—IL6—atopic dermatitis	7.72e-06	0.000119	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	7.7e-06	0.000118	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IL2—atopic dermatitis	7.6e-06	0.000117	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—IL6—atopic dermatitis	7.56e-06	0.000116	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CXCL8—atopic dermatitis	7.47e-06	0.000115	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	7.46e-06	0.000115	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	7.34e-06	0.000113	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	7.18e-06	0.00011	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—MAPK8—atopic dermatitis	7.14e-06	0.00011	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IL2—atopic dermatitis	7.14e-06	0.00011	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—IL6—atopic dermatitis	7.13e-06	0.00011	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—IL6—atopic dermatitis	7.1e-06	0.000109	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—MAPK8—atopic dermatitis	6.99e-06	0.000107	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CXCL8—atopic dermatitis	6.95e-06	0.000107	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—IL6—atopic dermatitis	6.73e-06	0.000103	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	6.67e-06	0.000103	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IL2—atopic dermatitis	6.64e-06	0.000102	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—IL6—atopic dermatitis	6.61e-06	0.000102	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—MAPK8—atopic dermatitis	6.57e-06	0.000101	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CXCL8—atopic dermatitis	6.27e-06	9.64e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PPARA—atopic dermatitis	6.24e-06	9.6e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—MAPK8—atopic dermatitis	6.11e-06	9.4e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	6.06e-06	9.31e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	6.02e-06	9.26e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL2—atopic dermatitis	6e-06	9.22e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—IL6—atopic dermatitis	5.97e-06	9.17e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL2—atopic dermatitis	5.79e-06	8.9e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CXCL8—atopic dermatitis	5.77e-06	8.87e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	5.76e-06	8.85e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL2—atopic dermatitis	5.76e-06	8.85e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	5.73e-06	8.81e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—MAPK8—atopic dermatitis	5.52e-06	8.48e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL2—atopic dermatitis	5.51e-06	8.47e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—IL6—atopic dermatitis	5.48e-06	8.43e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	5.33e-06	8.19e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	5.32e-06	8.17e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	5.3e-06	8.15e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	5.23e-06	8.04e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	5.12e-06	7.87e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL2—atopic dermatitis	5.08e-06	7.81e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—MAPK8—atopic dermatitis	5.07e-06	7.8e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—IL6—atopic dermatitis	5.06e-06	7.77e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL2—atopic dermatitis	5e-06	7.69e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PPARA—atopic dermatitis	4.98e-06	7.66e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	4.97e-06	7.65e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	4.9e-06	7.53e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	4.87e-06	7.49e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	4.76e-06	7.32e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	4.68e-06	7.19e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	4.6e-06	7.07e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IL6—atopic dermatitis	4.56e-06	7.01e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	4.55e-06	6.99e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	4.53e-06	6.96e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	4.51e-06	6.93e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IL6—atopic dermatitis	4.47e-06	6.86e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IL6—atopic dermatitis	4.19e-06	6.45e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	4.19e-06	6.44e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IL6—atopic dermatitis	3.9e-06	6e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PPARA—atopic dermatitis	3.85e-06	5.91e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL6—atopic dermatitis	3.52e-06	5.42e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL6—atopic dermatitis	3.4e-06	5.23e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL6—atopic dermatitis	3.38e-06	5.2e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL6—atopic dermatitis	3.24e-06	4.98e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL6—atopic dermatitis	2.99e-06	4.59e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL6—atopic dermatitis	2.94e-06	4.52e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	2.88e-06	4.42e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	2.67e-06	4.11e-05	CbGpPWpGaD
